250 related articles for article (PubMed ID: 19756920)
1. HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma.
Nicoli P; Familiari U; Bosa M; Allice T; Mete F; Morotti A; Cilloni D; Saglio G; Guerrasio A
Int J Hematol; 2009 Oct; 90(3):392-396. PubMed ID: 19756920
[TBL] [Abstract][Full Text] [Related]
2. [Two HHV8-related illnesses in a HIV-negative patient: Kaposi's sarcoma and multicentric Castleman's disease. Response to treatment with Rituximab and CHOP].
Pastor MA; Vasco B; Mosquera JM; Debén G; Bautista P; Requena L
Actas Dermosifiliogr; 2006; 97(6):385-90. PubMed ID: 16956518
[TBL] [Abstract][Full Text] [Related]
3. Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient.
Law AB; Ryan G; Lade S; Prince HM
Int J Hematol; 2010 Mar; 91(2):347-8; author reply 349. PubMed ID: 20146033
[No Abstract] [Full Text] [Related]
4. Complete remission in a pancytopenic HIV negative, HHV-8 positive patient with multicentric Castleman's disease induced with anti-CD20.
Cervera Grau JM; Galiana Esquerdo G; Llorca Ferrándiz C; Briceño García H; Díaz Castellano M; Férriz Moreno P
Clin Transl Oncol; 2006 Jul; 8(7):540-1. PubMed ID: 16870545
[TBL] [Abstract][Full Text] [Related]
5. Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab.
Ide M; Kawachi Y; Izumi Y; Kasagi K; Ogino T
Eur J Haematol; 2006 Feb; 76(2):119-23. PubMed ID: 16405432
[TBL] [Abstract][Full Text] [Related]
6. An HHV-8 Positive HIV Negative Multicentric Castleman's Disease, who Responded well to Rituximab Alone.
Kounatidis D; Rontogianni D; Sampaziotis D; Vardaka M; Giatra C; Dolapsakis C; Margellou E; Vallianou NG
Cardiovasc Hematol Disord Drug Targets; 2020; 20(1):84-86. PubMed ID: 30827270
[TBL] [Abstract][Full Text] [Related]
7. Human herpesvirus 8 DNA in HIV-negative Japanese patients with multicentric Castleman's disease and related diseases.
Tohda S; Murakami N; Nara N
Int J Mol Med; 2001 Nov; 8(5):549-51. PubMed ID: 11605026
[TBL] [Abstract][Full Text] [Related]
8. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy.
Corbellino M; Bestetti G; Scalamogna C; Calattini S; Galazzi M; Meroni L; Manganaro D; Fasan M; Moroni M; Galli M; Parravicini C
Blood; 2001 Dec; 98(12):3473-5. PubMed ID: 11719390
[TBL] [Abstract][Full Text] [Related]
9. Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient.
Murphy C; Hawkes E; Chionh F; Chong G
J Clin Pharm Ther; 2017 Feb; 42(1):111-114. PubMed ID: 27790727
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of iatrogenic multicentric Castleman's disease arising due to recrudescence of HHV-8 in a liver transplant patient.
Speicher DJ; Sehu MM; Mollee P; Shen L; Johnson NW; Faoagali JL
Am J Transplant; 2014 May; 14(5):1207-13. PubMed ID: 24674650
[TBL] [Abstract][Full Text] [Related]
11. Higher rate of progression in HIV- than in HIV+ patients after rituximab for HHV8+ multicentric Castleman disease.
Rasmussen C; Gérard L; Fadlallah J; Corvilain E; Galicier L; Meignin V; Oksenhendler E; Boutboul D
Blood Adv; 2023 Sep; 7(18):5663-5669. PubMed ID: 37288720
[TBL] [Abstract][Full Text] [Related]
12. Castleman's disease: from basic mechanisms to molecular therapeutics.
El-Osta HE; Kurzrock R
Oncologist; 2011; 16(4):497-511. PubMed ID: 21441298
[TBL] [Abstract][Full Text] [Related]
13. Multicentric Castleman's disease in HIV infection: a systematic review of the literature.
Mylona EE; Baraboutis IG; Lekakis LJ; Georgiou O; Papastamopoulos V; Skoutelis A
AIDS Rev; 2008; 10(1):25-35. PubMed ID: 18385778
[TBL] [Abstract][Full Text] [Related]
14. Multicentric Castleman's disease in India - Does EBV rather than HHV8 play a role?
Bhanvadia V; Shet T; Rao V; Epari S; Gujral S; Jain H; Bagal B; Sengar M
Indian J Pathol Microbiol; 2021; 64(2):302-309. PubMed ID: 33851624
[TBL] [Abstract][Full Text] [Related]
15. How I treat HHV8/KSHV-related diseases in posttransplant patients.
Riva G; Luppi M; Barozzi P; Forghieri F; Potenza L
Blood; 2012 Nov; 120(20):4150-9. PubMed ID: 22968461
[TBL] [Abstract][Full Text] [Related]
16. Successful rituximab treatment of an elderly Japanese patient with HHV8-positive, HIV-negative multicentric Castleman disease.
Kaga H; Kurahashi H; Kubota A; Hatano Y; Nanjo H; Wakui H; Takahashi N
Int J Hematol; 2022 Jan; 115(1):129-134. PubMed ID: 34591291
[TBL] [Abstract][Full Text] [Related]
17. Brief communication: rituximab in HIV-associated multicentric Castleman disease.
Bower M; Powles T; Williams S; Davis TN; Atkins M; Montoto S; Orkin C; Webb A; Fisher M; Nelson M; Gazzard B; Stebbing J; Kelleher P
Ann Intern Med; 2007 Dec; 147(12):836-9. PubMed ID: 18087054
[TBL] [Abstract][Full Text] [Related]
18. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.
Oksenhendler E; Boulanger E; Galicier L; Du MQ; Dupin N; Diss TC; Hamoudi R; Daniel MT; Agbalika F; Boshoff C; Clauvel JP; Isaacson PG; Meignin V
Blood; 2002 Apr; 99(7):2331-6. PubMed ID: 11895764
[TBL] [Abstract][Full Text] [Related]
19. Molecular Features of HHV8 Monoclonal Microlymphoma Associated with Kaposi Sarcoma and Multicentric Castleman Disease in an HIV-Negative Patient.
Rogges E; Pelliccia S; Savio C; Lopez G; Della Starza I; La Verde G; Di Napoli A
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612584
[TBL] [Abstract][Full Text] [Related]
20. Durable remission of HIV-negative, Kaposi's sarcoma herpes virus-associated multicentric Castleman disease in patient with rheumatoid arthritis treated with methotrexate.
Jacobs SA; Vidnovic N; Patel H; Soma LA; Chang Y; Bass N; Swerdlow SH
Clin Rheumatol; 2007 Jul; 26(7):1148-50. PubMed ID: 16572284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]